The reaction should be documented in your medical records, and you should be provided with clear guidance about avoiding the medication in future and identifying suitable alternatives
Safety and efficacy of oral semaglutide versus dulaglutide in Japanese patients with type 2 diabetes (PIONEER 10): an open-label, randomised, active-controlled, phase 3a trial
The association of obesity and cardiometabolic traits with incident HFpEF and HFrEF
While metformin has long served as the standard first-line therapy, many clinicians are now reconsidering whether a metformin-first and wait strategy is enough for this higher-risk population
Customized to your body and closely monitored by experienced providers, it supports lasting symptom relief and renewed balance
SIRT5 stabilizes mitochondrial glutaminase and supports breast cancer tumorigenesis